Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piero Picci

Showing results (51-60 of 272) with videos related to

Pageof 28
Sort By:
Spine|March 17, 2012
Osteosarcoma of the mobile spineJoseph Schwab, Alessandro Gasbarrini, Stefano Bandiera, et al.
Acta Oncologica (Stockholm, Sweden)|October 18, 2005
Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapyGaetano Bacci, Antonio Briccoli, Alessandra Longhi, et al.
Anti-Cancer Drugs|March 22, 2006
No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcomaGaetano Bacci, Loretta Loro, Alessandra Longhi, et al.
Clinical Sarcoma Research|February 10, 2018
Intraosseous papillary intralymphatic angioendothelioma (PILA): one new case and review of the literatureMarco Gambarotti, Alberto Righi, Marta Sbaraglia, et al.
American Journal of Cancer Research|January 26, 2016
Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcomaMaria Serena Benassi, Laura Pazzaglia, Chiara Novello, et al.
Plos One|December 10, 2014
p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expressionChiara Novello, Laura Pazzaglia, Amalia Conti, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2013
Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcomaIsidro Machado, José Antonio López Guerrero, Samuel Navarro, et al.
Pathology, Research and Practice|February 21, 2021
Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?Isidro Machado, Samuel Navarro, José A López-Guerrero, et al.
Virchows Archiv : an International Journal of Pathology|August 18, 2012
Epithelial cell adhesion molecules and epithelial mesenchymal transition (EMT) markers in Ewing's sarcoma family of tumors (ESFTs). Do they offer any prognostic significance?Isidro Machado, José A López-Guerrero, Samuel Navarro, et al.
International Journal of Cancer|December 4, 2003
Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behavior of Ewing's sarcoma cells: therapeutic prospectsStefania Benini, Maria Cristina Manara, Vanessa Cerisano, et al.
Pageof 28

Showing results (51-60 of 272) with videos related to

Sort By:
Pageof 28
Spine|March 17, 2012
Osteosarcoma of the mobile spineJoseph Schwab, Alessandro Gasbarrini, Stefano Bandiera, et al.
Acta Oncologica (Stockholm, Sweden)|October 18, 2005
Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapyGaetano Bacci, Antonio Briccoli, Alessandra Longhi, et al.
Anti-Cancer Drugs|March 22, 2006
No correlation between methotrexate serum level and histologic response in the pre-operative treatment of extremity osteosarcomaGaetano Bacci, Loretta Loro, Alessandra Longhi, et al.
Clinical Sarcoma Research|February 10, 2018
Intraosseous papillary intralymphatic angioendothelioma (PILA): one new case and review of the literatureMarco Gambarotti, Alberto Righi, Marta Sbaraglia, et al.
American Journal of Cancer Research|January 26, 2016
Tissue and serum IGFBP7 protein as biomarker in high-grade soft tissue sarcomaMaria Serena Benassi, Laura Pazzaglia, Chiara Novello, et al.
Plos One|December 10, 2014
p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expressionChiara Novello, Laura Pazzaglia, Amalia Conti, et al.
Virchows Archiv : an International Journal of Pathology|May 18, 2013
Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcomaIsidro Machado, José Antonio López Guerrero, Samuel Navarro, et al.
Pathology, Research and Practice|February 21, 2021
Neuroendocrine differentiation in a large series of genetically-confirmed Ewing's sarcoma family tumor: Does it provide any diagnostic or prognostic information?Isidro Machado, Samuel Navarro, José A López-Guerrero, et al.
Virchows Archiv : an International Journal of Pathology|August 18, 2012
Epithelial cell adhesion molecules and epithelial mesenchymal transition (EMT) markers in Ewing's sarcoma family of tumors (ESFTs). Do they offer any prognostic significance?Isidro Machado, José A López-Guerrero, Samuel Navarro, et al.
International Journal of Cancer|December 4, 2003
Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behavior of Ewing's sarcoma cells: therapeutic prospectsStefania Benini, Maria Cristina Manara, Vanessa Cerisano, et al.
Pageof 28